H.C. Wainwright also maintained a Buy rating on I-Mab, despite lowering its price target from $8.00 to $7.00, citing the company’s strategic focus on Givastomig.

Apple’s latest research hints that a long-forgotten AI technique could have new potential for generating images. Here’s the breakdown.

The Vera C. Rubin Observatory has released its first images, providing a staggering glimpse at the observing power it will unleash when it begins its decade-long survey.

Google has unveiled its latest text-to-image models Imagen 4 and Imagen 4 Ultra with the usual promise of "significantly improved text rendering" over the previous version, Imagen 3.

Alibaba Group Holding Ltd. unveiled a new iteration of its artificial-intelligence technology that will make it easier for users to generate and modify images from texts and visuals, as the ...

A pink-and-blue feast of stellar nurseries and a dense cluster of our neighbouring galaxies appear in the first glimpses of space from the Vera C. Rubin Observatory, which is set to transform our ...

The long-awaited Vera C. Rubin Observatory, a cutting-edge new telescope perched atop a mountain in Chile, released its first images of the universe on June 23—and its views are just as jaw ...

Of the many Spanish-made firearms to emerge throughout the 19th and 20th century, one of the most recognizable is the Star ...

Project scientists and others gathered at the National Academy of Sciences building to see the first images from the new Vera C. Rubin Observatory, named after the trailblazing astronomer and NAS ...

The Vera C. Rubin Observatory publishes its first images on 23 June 2025 and will in future explore dark matter and dark energy as well as distant galaxies, supernovae and active centres of galaxies ...

What just happened? The first incredible images taken by the car-sized camera at the Vera C. Rubin Observatory have been released. The pictures show distant galaxies and dust clouds thousands of ...

Investing.com - H.C. Wainwright maintained its buy rating and $7.00 price target on I-Mab (NASDAQ: IMAB) stock Tuesday as the company prepares to present Phase 1b data for its cancer drug ...